Skip to content

Journal of Neurological Sciences

ISSN 1302-1664

2 papers in the library · 88 citations · publishing 2021-2022

Papers

Sort Most recent Most cited

Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence.

Journal of Neurological Sciences 2022 Subha Subramanian, S. Haroutounian, Ben J Palanca et al. 58 citations

Ketamine is an anesthetic drug which is now used to treat chronic pain conditions and psychiatric disorders, especially depression. It is an N-methyl-D-aspartate (NMDA) receptor antagonist with additional effects on α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, opioid receptors, and monoaminergic...

Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.

Journal of Neurological Sciences December 1, 2021 Craig S Pearson, J. Siegel, J. Gold 30 citations

There is a serious need for novel therapies that treat individuals with depression, including major depressive disorder (MDD) and treatment-resistant depression (TRD). An emerging body of research has demonstrated that psychedelic drugs such as psilocybin, combined with supportive psychotherapy, exert rapid and sustained antidepressant effects. The use of psychedelics is not new: they have a...